EBOLA VILLAGE
indie_games_studio · 2025 · $16.99 · Action · deal grade B
Measured on 2026-09-23 18:58 UTC, 12 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.
- Estimated net residual revenue: $503 to $755 per month
- Opportunity: $849 per month at x1.35 dormancy
- Estimated lifetime owners: 14.8k
- 79% positive across 419 reviews · 4.4 reviews/month
Why it's flagged
- Developer silent for 16 months
- Studio quiet across its whole catalog
Analyst notes (AI-assisted)
Note written 2026-09-06; the live figures above take precedence over any numbers in it.
A 2025 action title with an epidemiological theme, released by a Russian indie studio with modest Steam traction.
Ebola Village sits in a difficult position: it carries niche appeal (80% positive sentiment among engaged players) but faces headwinds from low concurrent population, minimal developer engagement post-launch, and a premise that restricts mainstream discoverability. The residual margin is thin and shrinking; this is a watch candidate rather than an acquisition target unless the buyer has a specific use case for Russian-language catalog depth or experimental IP. The studio's fading status and two-title output suggest limited institutional capacity. Most realistic play: watch.
- Risk: Thematic content (epidemiological framing) may limit algorithmic visibility and platform promotion, constraining organic growth.
- Risk: Sample reviews cite janky UX and unclear first-task onboarding; technical polish gaps may explain churn after tutorial.
- Risk: Developer has posted no updates in ~15 months and shows no signs of live-ops support or content roadmap.
This case as Markdown · Estimates carry ±30-50% error per title.